BORDERLINE OVARIAN MUCINOUS TUMOR

Clinical trials for BORDERLINE OVARIAN MUCINOUS TUMOR explained in plain language.

Never miss a new study

Get alerted when new BORDERLINE OVARIAN MUCINOUS TUMOR trials appear

Sign up with your email to follow new studies for BORDERLINE OVARIAN MUCINOUS TUMOR, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1

Major cancer trial tests new drug combo for Tough-to-Treat ovarian cancer

Disease control Ongoing

This large, late-stage trial is testing which combination of chemotherapy drugs works best for women with a specific type of ovarian or fallopian tube cancer (mucinous adenocarcinoma). It compares two standard drug pairs, with or without an added drug (bevacizumab) that blocks tu…

Matched conditions: BORDERLINE OVARIAN MUCINOUS TUMOR

Phase: PHASE3 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control

Last updated Mar 24, 2026 12:02 UTC

BORDERLINE OVARIAN MUCINOUS TUMOR

Get alerted when new BORDERLINE OVARIAN MUCINOUS TUMOR trials appear

Major cancer trial tests new drug combo for Tough-to-Treat ovarian cancer